<?xml version="1.0" encoding="UTF-8"?>
<p>Analyses of efficacy outcomes were conducted using the perprotocol (PP) and the modified intention-to-treat (MITT) approaches, with the last observation carried forward method. For the safety evaluation, all patients who had received at least one dose of study drugs were analyzed. Statistical analysis was performed using SPSS version 22.0. A 
 <italic>p</italic> value of &lt;0.05 was considered to indicate statistical significance.
</p>
